Company profile
Evox Therapeutics - Transformative Exosome Therapeutics
EVOX Therapeutics Limited is a UK company with status active founded in 2016 based in South East England.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MjIyNDUzM2FkaXF6a2N4
Published 06 Nov 2024 03:33
Company registered at Companies House
Exosome therapeutic technology company
Evox Therapeutics uses vesicles, small bodies made of cellular membranes, to encase drugs and treat a range of severe diseases.
Development of therapeutic exosome technology. Investment from Oxford Sciences Innovation
1 Feb 2019 to 31 Mar 2021
Argininosuccinate lyase (ASL) deficiency is the second most common urea cycle defect. In the most severe form of the disease, symptoms present early in the new-born period progressing to coma and consequent death if untreated. Later presentation can present with aspecific neuro-disability. Patients are managed by pharmacological and dietary intervention, ...
